...
首页> 外文期刊>The Lancet >Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
【24h】

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

机译:在一般人群中,估计的肾小球滤过率和蛋白尿与全因和心血管死亡率的关联:一项协作荟萃分析。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Substantial controversy surrounds the use of estimated glomerular filtration rate (eGFR) and albuminuria to define chronic kidney disease and assign its stages. We undertook a meta-analysis to assess the independent and combined associations of eGFR and albuminuria with mortality. METHODS: In this collaborative meta-analysis of general population cohorts, we pooled standardised data for all-cause and cardiovascular mortality from studies containing at least 1000 participants and baseline information about eGFR and urine albumin concentrations. Cox proportional hazards models were used to estimate hazard ratios (HRs) for all-cause and cardiovascular mortality associated with eGFR and albuminuria, adjusted for potential confounders. FINDINGS: The analysis included 105,872 participants (730,577 person-years) from 14 studies with urine albumin-to-creatinine ratio (ACR) measurements and 1,128,310 participants (4,732,110 person-years) from seven studies with urine protein dipstick measurements. In studies with ACR measurements, risk of mortality was unrelated to eGFR between 75 mL/min/1.73 m(2) and 105 mL/min/1.73 m(2) and increased at lower eGFRs. Compared with eGFR 95 mL/min/1.73 m(2), adjusted HRs for all-cause mortality were 1.18 (95% CI 1.05-1.32) for eGFR 60 mL/min/1.73 m(2), 1.57 (1.39-1.78) for 45 mL/min/1.73 m(2), and 3.14 (2.39-4.13) for 15 mL/min/1.73 m(2). ACR was associated with risk of mortality linearly on the log-log scale without threshold effects. Compared with ACR 0.6 mg/mmol, adjusted HRs for all-cause mortality were 1.20 (1.15-1.26) for ACR 1.1 mg/mmol, 1.63 (1.50-1.77) for 3.4 mg/mmol, and 2.22 (1.97-2.51) for 33.9 mg/mmol. eGFR and ACR were multiplicatively associated with risk of mortality without evidence of interaction. Similar findings were recorded for cardiovascular mortality and in studies with dipstick measurements. INTERPRETATION: eGFR less than 60 mL/min/1.73 m(2) and ACR 1.1 mg/mmol (10 mg/g) or more are independent predictors of mortality risk in the general population. This study provides quantitative data for use of both kidney measures for risk assessment and definition and staging of chronic kidney disease. FUNDING: Kidney Disease: Improving Global Outcomes (KDIGO), US National Kidney Foundation, and Dutch Kidney Foundation.
机译:背景:大量争议围绕评估肾小球滤过率(eGFR)和蛋白尿来定义慢性肾脏疾病并确定其阶段。我们进行了荟萃分析,以评估eGFR和蛋白尿与死亡率的独立和联合关联。方法:在这项针对一般人群的协作性荟萃分析中,我们汇总了包含至少1000名参与者以及有关eGFR和尿白蛋白浓度的基线信息的研究的全因和心血管死亡率的标准化数据。使用Cox比例风险模型评估与eGFR和蛋白尿相关的全因和心血管死亡率的风险比(HRs),并针对潜在的混杂因素进行了调整。结果:该分析包括来自14项尿白蛋白与肌酐比(ACR)测量的研究的105,872名参与者(730,577人年)和来自七项尿蛋白试纸测量的1,128,310名参与者(4,732,110人年)。在使用ACR测量的研究中,死亡风险与eGFR在75 mL / min / 1.73 m(2)和105 mL / min / 1.73 m(2)之间无关,并在较低eGFR下增加。与eGFR 95 mL / min / 1.73 m(2)相比,eGFR 60 mL / min / 1.73 m(2)的全因死亡率调整后的HRs为1.18(95%CI 1.05-1.32),1.57(1.39-1.78) 45 mL / min / 1.73 m(2)和3.14(2.39-4.13)进行15 mL / min / 1.73 m(2)的洗脱。在无阈值影响的对数-对数尺度上,ACR与死亡风险呈线性相关。与ACR 0.6 mg / mmol相比,ACR 1.1 mg / mmol的全因死亡率调整后的HRs为1.20(1.15-1.26),3.4 mg / mmol的调整后的HRs为1.63(1.50-1.77),33.9的调整后的HRs为2.22(1.97-2.51)毫克/毫摩尔。没有相互作用的证据,eGFR和ACR与死亡风险成倍相关。在心血管死亡率和使用量油尺测量的研究中也记录了类似的发现。解释:eGFR低于60 mL / min / 1.73 m(2)和ACR 1.1 mg / mmol(10 mg / g)或更高是一般人群中死亡风险的独立预测因子。这项研究提供了定量数据,用于将两种肾脏措施用于风险评估以及慢性肾脏疾病的定义和分期。资金:肾脏疾病:改善全球结局(KDIGO),美国国家肾脏基金会和荷兰肾脏基金会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号